Literature DB >> 20537965

Micro-RNAs and breast cancer.

John Le Quesne1, Carlos Caldas.   

Abstract

Micro-RNAs (miRs) are a recently described class of genes, encoding small non-coding RNA molecules, which primarily act by down-regulating the translation of target mRNAs. miRs are involved in a range of normal physiological processes, notably differentiation and cell type determination. It has become apparent that they are also key factors in cancer, playing both oncogenic and tumour-suppressing roles. We discuss here what is known of miR biology in the normal breast, and of their emerging roles in breast cancer. (c) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20537965      PMCID： PMC5527936          DOI： 10.1016/j.molonc.2010.04.009

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


  136 in total

1.  Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression.

Authors:  Anna Git; Heidi Dvinge; Mali Salmon-Divon; Michelle Osborne; Claudia Kutter; James Hadfield; Paul Bertone; Carlos Caldas
Journal:  RNA       Date:  2010-04-01       Impact factor: 4.942

2.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer.

Authors:  J Michael Thomson; Martin Newman; Joel S Parker; Elizabeth M Morin-Kensicki; Tricia Wright; Scott M Hammond
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

3.  MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Authors:  Raffaele Baffa; Matteo Fassan; Stefano Volinia; Brian O'Hara; Chang-Gong Liu; Juan P Palazzo; Marina Gardiman; Massimo Rugge; Leonard G Gomella; Carlo M Croce; Anne Rosenberg
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

4.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

5.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

6.  The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

Authors:  Leandro Castellano; Georgios Giamas; Jimmy Jacob; R Charles Coombes; Walter Lucchesi; Paul Thiruchelvam; Geraint Barton; Long R Jiao; Robin Wait; Jonathan Waxman; Gregory J Hannon; Justin Stebbing
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

7.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

8.  MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation.

Authors:  Ulf Andersson Ørom; Finn Cilius Nielsen; Anders H Lund
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

9.  Characterisation of microRNA expression in post-natal mouse mammary gland development.

Authors:  Stefanie Avril-Sassen; Leonard D Goldstein; John Stingl; Cherie Blenkiron; John Le Quesne; Inmaculada Spiteri; Konstantina Karagavriilidou; Christine J Watson; Simon Tavaré; Eric A Miska; Carlos Caldas
Journal:  BMC Genomics       Date:  2009-11-20       Impact factor: 3.969

10.  Lin28 promotes transformation and is associated with advanced human malignancies.

Authors:  Srinivas R Viswanathan; John T Powers; William Einhorn; Yujin Hoshida; Tony L Ng; Sara Toffanin; Maureen O'Sullivan; Jun Lu; Letha A Phillips; Victoria L Lockhart; Samar P Shah; Pradeep S Tanwar; Craig H Mermel; Rameen Beroukhim; Mohammad Azam; Jose Teixeira; Matthew Meyerson; Timothy P Hughes; Josep M Llovet; Jerald Radich; Charles G Mullighan; Todd R Golub; Poul H Sorensen; George Q Daley
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330
View more
  33 in total

1.  On the molecular biology of breast cancer.

Authors:  Anne-Lise Børresen-Dale; Therese Sørlie; Vessela N Kristensen
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

Review 2.  Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.

Authors:  Sasagu Kurozumi; Yuri Yamaguchi; Masafumi Kurosumi; Miki Ohira; Hiroshi Matsumoto; Jun Horiguchi
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

3.  MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.

Authors:  Anna Aakula; Suvi-Katri Leivonen; Petteri Hintsanen; Tero Aittokallio; Yvonne Ceder; Anne-Lise Børresen-Dale; Merja Perälä; Päivi Östling; Olli Kallioniemi
Journal:  Mol Oncol       Date:  2015-03-21       Impact factor: 6.603

4.  MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Authors:  Lei Huo; Yan Wang; Yun Gong; Savitri Krishnamurthy; Jing Wang; Lixia Diao; Chang-Gong Liu; Xiuping Liu; Feng Lin; William F Symmans; Wei Wei; Xinna Zhang; Li Sun; Ricardo H Alvarez; Naoto T Ueno; Tamer M Fouad; Kenichi Harano; Bisrat G Debeb; Yun Wu; James Reuben; Massimo Cristofanilli; Zhuang Zuo
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

Review 5.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis.

Authors:  Stephanos Pavlides; Iset Vera; Ricardo Gandara; Sharon Sneddon; Richard G Pestell; Isabelle Mercier; Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Antioxid Redox Signal       Date:  2011-11-17       Impact factor: 8.401

6.  Her-2 expression regulated by downregulation of miR-9 and which affects chemotherapeutic effect in breast cancer.

Authors:  G Sun; L Sun; Y Liu; H Xing; K Wang
Journal:  Cancer Gene Ther       Date:  2017-03-31       Impact factor: 5.987

7.  MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.

Authors:  Gillian Browne; Julie A Dragon; Deli Hong; Terri L Messier; Jonathan A R Gordon; Nicholas H Farina; Joseph R Boyd; Jennifer J VanOudenhove; Andrew W Perez; Sayyed K Zaidi; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Tumour Biol       Date:  2016-01-09

8.  miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w.

Authors:  Lei Shen; Jia Li; Liping Xu; Jie Ma; Hua Li; Xigang Xiao; Junyong Zhao; Lin Fang
Journal:  Exp Ther Med       Date:  2011-12-22       Impact factor: 2.447

Review 9.  MicroRNA biomarkers in glioblastoma.

Authors:  Simon Kjær Hermansen; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2013-05-23       Impact factor: 4.130

10.  MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.

Authors:  Chuankui Wei; Qifeng Luo; Xiaoguo Sun; Dengfeng Li; Hongming Song; Xiaoyu Li; Jialu Song; Kaiyao Hua; Lin Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.